Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Severe maternal complications in pregnancy in sub-Saharan Africa contribute to high maternal mortality and morbidity. Incidence data on severe maternal complications, life-threatening conditions, maternal deaths and birth outcomes are essential for clinical audit and to inform trial design of the types and frequency of expected severe adverse events (SAEs). However, such data are very limited, especially in sub-Saharan Africa. We set up standardized, systematic clinical surveillance embedded into routine clinical care in a rural county hospital in Kenya. Pregnant women and newborns are systematically assessed and investigated. Data are reported using a standardized Maternal Admission Record that forms both the hospital's clinical record and the data collection tool. Integrating clinical surveillance with routine clinical care is feasible and should be expanded in sub-Saharan Africa, both for improving clinical practice and as a basis for intervention studies to reduce maternal and newborn mortality and morbidity where rates are highest.

Original publication

DOI

10.1016/j.vaccine.2015.07.086

Type

Journal article

Journal

Vaccine

Publication Date

25/11/2015

Volume

33

Pages

6466 - 6468

Keywords

Surveillance maternal pregnancy vaccine, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Immunization, Infant, Newborn, Kenya, Pregnancy, Pregnancy Complications, Product Surveillance, Postmarketing, Vaccines